ASRS – American Society of Retina Specialists’ Post

Ophthopedia Update:Xen-DS: a novel technique of ab externo Xen implantation augmented with a modified deep sclerectomy for surgical treatment of glaucoma: Eye, Published online: 21 May 2024; doi:10.1038/s41433-024-03146-6Xen-DS: a novel technique of ab externo Xen implantation augmented with a modified deep sclerectomy for surgical treatment of glaucoma #Ophthalmology #Eye #Ophthotwitter

Researchers assessed the use of anterior-segment optical coherence tomography (AS-OCT) to evaluate bleb function in post-surgical eyes and found that this “objective” method may help guide pharmacologic treatment and early surgical intervention in these patients. Read the full article here ⤵️ #Glaucoma #GlaucomaSurgery #EyeDisease

ICYMI: Cornea Update: Alternative Approach for the Treatment of Conjunctivochalasis: Plasma-Based Conjunctivoplasty: Purpose: The aim of this study was to evaluate the efficacy of plasma-based conjunctivoplasty as a new surgical approach for conjunctivochalasis. Methods: This prospective, noncomparative, interventional study included research on 42 eyes of 33 patients who underwent plasma therapy because of conjunctivochalasis between February 2020 and December 2021. Maintaining a 2-mm distance from the limbus, at least 3 lines (approximately 2 mm deep) of plasma therapy were applied to the conjunctiva from the temporal quadrant to the nasal quadrant. Patient symptoms, the fluorescein clearance test, ocular surface integrity with fluorescein staining, the Ocular Surface Disease Index questionnaire, tear breakup time (TBUT), tear meniscus height, and complications were evaluated. Results: The mean patient age at the time of surgery was 67.3 ± 7.2 (range: 54–81) years. After surgery, the grades of conjunctivochalasis decreased in all patients. Although epiphora was present in 28 eyes (66.6%) preoperatively, none of the cases had epiphora during the follow-up period. The Ocular Surface Disease Index score improved significantly from 34.7 ± 10.3 preoperatively to 5.0 ± 4.2 3 months postoperatively (P http://dlvr.it/T9Q1QG #Cornea #MostPopularArticles #Ophthalmology

Ophthopedia Update:COMPARISON OF SURGICAL OUTCOMES OF MACULAR TELANGIECTASIA TYPE 2–ASSOCIATED MACULAR HOLE WITH IDIOPATHIC MACULAR HOLE: A Tertiary Center Review: Purpose: To assess the longitudinal surgical outcomes of macular telangiectasia Type 2 macular hole (MacTel-MH) and compare them with those of idiopathic MH. Methods: This retrospective, single-tertiary center study included patients who underwent MH surgery between January 2015 and September 2023. Patients with characteristic optical coherence tomography findings of MacTel in both eyes or those who underwent fluorescence angiography were classified as having MacTel MH. Baseline and postoperative best-corrected visual acuity and optical coherence tomography parameters were reviewed. Results: Totally, 27 and 243 eyes with MacTel and idiopathic MH, respectively, were included. Macular hole closure rate was better achieved in idiopathic than in MacTel MH group at two years postoperatively. Temporal recovery of ellipsoid zone and external limiting membrane was more prominent in MacTel than in idiopathic MH group. Statistically significant visual acuity improvement was seen between three months and two years postoperatively in MacTel MH group. Conclusion: To the best of our knowledge, this is the first study to analyze the surgical outcomes of MacTel MH in both anatomical and functional aspects and compare them with patients with idiopathic MH. Postoperative microglia change would have affected the restoration of outer retinal layer of patients; however, further studies are needed for clarification. #Ophthotwitter #Ophthalmology #Retina

The Steerable sheath revolution! Do you all use steerable sheaths and transfemoral access in FB-EVAR? This study compared outcomes of FB-EVAR using upper extremity (UE) or Transfemoral (TF) access for target artery (TA) incorporation. The study analyzed data from patients undergoing FB-EVAR between November 2013 and December 2022 (n=541). Patients were categorized based on the type of access used. Procedural details, outcomes, and complications were compared between UE and TF access groups. Key findings include: 🐅 TF access increased over time, with significant improvements in procedural metrics and decreased adverse events compared to UE access. 🐴 TF access was associated with shorter procedure times, lower blood loss, and fewer adverse events, particularly cerebrovascular events. 🐂 Technical success rates were high and comparable between UE and TF access groups. 🐗 TF access was effective even for devices with directional branches, contradicting the belief that it poses greater technical challenges. 🐃 There were no significant differences in radiation exposure between UE and TF access groups. In conclusion: a total TF approach for FB-EVAR is increasingly favored and has demonstrated favorable outcomes compared to UE access, even for devices with directional branches. This study suggests that UE access may carry a higher risk of adverse events, particularly cerebrovascular events, and supports the routine use of TF access for FB-EVAR. Link to article: https://lnkd.in/e_SQ2bXW Congratulations to the authors: Thomas Mesnard Andrea Vacirca, Aidin Baghbani Oskouei, Titia Sulzer, Safa Savadi, Lucas Ruiter Kanamori, Emanuel R. Tenorio, Aleem Mirza, Naveed Saqib, Alexandre Bernardo C Mendes, Ying Huang, Gustavo Oderich MD Please also read this interesing take and 'how I use it' piece on this topic by Stéphan Haulon, Ming Guo and dominique fabre: https://lnkd.in/emvWJggH Both published in the Journal of Vascular Surgery. #FEVAR #BEVAR #aneurysm #endovascular

Cardiac Surgeons: New Study Examines Radiation Exposure During TAVR A recent study in the Annals of Thoracic Surgery highlights the importance of radiation safety for cardiac surgeons performing TAVR procedures. TAVR, while essential for treating aortic stenosis, exposes surgeons to ionizing radiation. The study suggests surgeons receive higher radiation doses due to their positioning during the procedure. RADPAD® Radiation Protection Shields can help minimize this risk. Backed by over 40 clinical studies, our lightweight, disposable shields offer a simple solution for a safer work environment. Protect yourself and your team! Choose RADPAD® and prioritize your health. Read more about the study here: https://lnkd.in/gHHNJ2ry #RADPAD #RadiationProtection #TAVR #CardiacSurgery #MedEd #CardiovascularHealth

Introducing our iPeer Review series! For this series physicians will be highlighting peer reviewed articles to share with you all some of the latest research in #eyecare. In our first video we have special guest Dr. William Soscia , Medical Director at Center For Sight in Sarasota, Florida discussing " Clinical performance after implantation of the Symfony extended depth of focus intraocular lens in the dominant eye and the Synergy presbyopia correcting intraocular lens in the non-dominant eye." This study looked to evaluate subjective and objective outcomes after combined implantation of an extended depth of focus (EDOF) intraocular lens (IOL) and a combined technology multifocal lens (CT-IOL). References: Soscia, William L. MD1,a; DeRojas, Joaquin O MD1; Mathews, Priya M. MD1; Brutsky, Amy BA1; Solomon, Kerry D. MD2; Potvin, Richard MASc, OD3; Sandoval, Helga P. MD, MSCR2. Clinical performance after implantation of the Symfony extended depth of focus intraocular lens in the dominant eye and the Synergy presbyopia correcting intraocular lens in the non-dominant eye. Journal of Cataract & Refractive Surgery ():10.1097/j.jcrs.0000000000001412, February 01, 2024. | DOI: 10.1097/j.jcrs.0000000000001412 Johnson & Johnson Vision Johnson & Johnson MedTech #symfony #iol #cataract Priya Mathews Joaquin De Rojas Kerry Solomon, M.D. Journal of Cataract & Refractive Surgery®

It's another FIRST for Joseph J. Ricotta MD, MS, DFSVS, FACS, National Medical Director, Vascular Surgery and Endovascular Therapy, Tenet Healthcare and the vascular team at Delray! Dr. Ricotta and his team are the first in Palm Beach County to place @Abbott's Esprit BTK Everolimus Eluting Resorbable Scaffold! This is a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving. Previously, the standard of care has been balloon angioplasty, which relies on a small balloon delivered via a catheter to the blockage to compress it against the arterial wall, opening the vessel and restoring blood flow. However, blockages treated only with balloon angioplasty have poor short- and long-term results, and in many instances the vessels become blocked again, requiring additional treatment. The Esprit BTK System is a dissolvable stent and is comprised of material similar to dissolving sutures. The device is implanted during a catheter-based minimally invasive procedure via a small incision in the leg. Once the blockage is open, the Esprit BTK scaffold helps heal the vessel and provides support for approximately three years until the vessel is strong enough to remain open on its own. For more information on Dr. Ricotta and @Prime Vascular Institute visit https://lnkd.in/ernivBk9 We are #DelrayMedicalCenter. #strongertogetherforyou #PBHNProud #palmbeachhealthnetwork #palmbeachhealthnetworkphysiciangroup

Maria Antonella Ruffino, MD, EBIR, FCIRSE presents a case of a 74-year-old male patient with a right common iliac artery rupture. A 74-year-old patient presented with a rare and incidental finding of a right common iliac artery rupture, discovered during a CT follow-up for myelofibrosis. This case underscores the importance of vigilance in routine imaging, revealing critical vascular complications that require urgent attention. The rupture was located just 3mm below the takeoff of the right common iliac artery, a position that presented significant surgical challenges. This highlights the intricate nature of vascular surgery and the precise skills required to manage such delicate anatomical structures. Detailed CT imaging was crucial in diagnosing the rupture and understanding the extent of the arterial damage. This reinforces the role of advanced imaging techniques in diagnosing and managing vascular emergencies with precision. The patient's aorta was severely calcified, complicating the intervention. Vascular calcification often complicates endovascular procedures, requiring specialised techniques and careful planning to ensure successful outcomes. Cases like this emphasize the need for a collaborative approach involving vascular surgeons, radiologists, and other specialists. A multidisciplinary strategy is essential to address the complexities of vascular injuries and optimise patient care. #viocongress #vascular

Cornea Update: Alternative Approach for the Treatment of Conjunctivochalasis: Plasma-Based Conjunctivoplasty: Purpose: The aim of this study was to evaluate the efficacy of plasma-based conjunctivoplasty as a new surgical approach for conjunctivochalasis. Methods: This prospective, noncomparative, interventional study included research on 42 eyes of 33 patients who underwent plasma therapy because of conjunctivochalasis between February 2020 and December 2021. Maintaining a 2-mm distance from the limbus, at least 3 lines (approximately 2 mm deep) of plasma therapy were applied to the conjunctiva from the temporal quadrant to the nasal quadrant. Patient symptoms, the fluorescein clearance test, ocular surface integrity with fluorescein staining, the Ocular Surface Disease Index questionnaire, tear breakup time (TBUT), tear meniscus height, and complications were evaluated. Results: The mean patient age at the time of surgery was 67.3 ± 7.2 (range: 54–81) years. After surgery, the grades of conjunctivochalasis decreased in all patients. Although epiphora was present in 28 eyes (66.6%) preoperatively, none of the cases had epiphora during the follow-up period. The Ocular Surface Disease Index score improved significantly from 34.7 ± 10.3 preoperatively to 5.0 ± 4.2 3 months postoperatively (P http://dlvr.it/T8rcC0 #Cornea #MostPopularArticles #Ophthalmology